AGIOS PHARMACEUTICALS

Lobbying client · Massachusetts · filed 2026 to 2026

Biotech/biopharmaceutical company

$10,000 Reported spend

2 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page is grouped by the client's LDA id (73290), not by name.

Firms hired 1

GRIDIRON PUBLIC AFFAIRS, LLC $10,000 2 filings

Bills named in these filings 2

HR 5094
Protect Patients from Costly Care Act

1 filing
HR 5187
To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufa…

1 filing

Reported by year 1 year

2026 $10,000 2 filings

Issues lobbied 1

Health Issues 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 2 total

Q2

GRIDIRON PUBLIC AFFAIRS, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 16, 2026

View → RR

GRIDIRON PUBLIC AFFAIRS, LLC

2nd Quarter (Apr 1 - June 30) 2026 · posted May 26, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.